| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 02 | 2 | CDC | 11/18/2024 | $0 |
| 2025 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 01 | 2 | CDC | 10/30/2024 | $0 |
| 2025 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 01 | 2 | CDC | 10/30/2024 | $0 |
| 2025 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU3HCK000021 | Strengthening National Surveillance Systems for Antimicrobial Resistance, Hospital Acquired Infections and Infection Prevention and Control towards Prevention, Detection and Response to outbreaks | 01 | 3 | CDC | 11/19/2024 | $0 |
| 2025 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 02 | 2 | CDC | 11/18/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | D43TW009771 | HIV CO-INFECTIONS IN UGANDA | 002 | 10 | NIH | 10/17/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | D43TW009771 | HIV CO-INFECTIONS IN UGANDA | 001 | 10 | NIH | 10/17/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | D43TW009771 | HIV CO-INFECTIONS IN UGANDA | 000 | 10 | NIH | 10/17/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 02 | 2 | CDC | 11/18/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 01 | 2 | CDC | 10/30/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2023 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2022 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2022 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2022 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2022 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2022 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2022 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2022 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
| 2025 | 2022 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 01 | 5 | CDC | 10/17/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $31,023,723 ) (Continued on the next page) |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | R21TW012988 | Late Neurological Sequelae after Cryptococcal Meningitis | 000 | 1 | NIH | 8/19/2024 | $174,687 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | K43TW011987 | Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa | 000 | 4 | NIH | 5/6/2024 | $91,459 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | K43TW011987 | Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa | 000 | 4 | NIH | 5/6/2024 | $100 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | R01AI150523 | Clinical and immunological impact of Schistosoma mansoni infection and treatment on the course of chronic hepatitis B virus (HBV) infection in Uganda | 000 | 5 | NIH | 4/18/2024 | $130,925 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2HGH000045 | Strengthening Partnerships for Preparedness and Response in Uganda | 00 | 5 | CDC | 6/28/2024 | $390,000 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | K43TW012839 | Integrating tuberculosis treatment into community pharmacies to improve TB/HIV outcomes in Uganda. | 000 | 1 | NIH | 8/5/2024 | $109,704 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | K43TW012637 | Peer delivered HIV/syphilis self-testing with assisted partner notification services for men who have sex with men (MSM) in Uganda | 001 | 2 | NIH | 6/26/2024 | $59,903 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | K43TW012637 | Peer delivered HIV/syphilis self-testing with assisted partner notification services for men who have sex with men (MSM) in Uganda | 001 | 2 | NIH | 6/26/2024 | $50,000 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU3HCK000021 | Strengthening National Surveillance Systems for Antimicrobial Resistance, Hospital Acquired Infections and Infection Prevention and Control towards Prevention, Detection and Response to outbreaks | 00 | 3 | CDC | 8/30/2024 | $200,000 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 00 | 2 | CDC | 8/16/2024 | $9,717,021 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 00 | 2 | CDC | 8/16/2024 | $0 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002306 | Sustaining Local Efforts for Epidemic Control | 00 | 5 | CDC | 7/30/2024 | $1,388,500 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002306 | Sustaining Local Efforts for Epidemic Control | 00 | 5 | CDC | 7/30/2024 | $0 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002309 | Attaining and sustaining HIV epidemic control in the West and West Nile regions of Uganda through optimization of high impact interventions to achieve UNAIDS 95:95:95 targets. | 00 | 5 | CDC | 8/8/2024 | $2,464,005 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-McKinnell Knowledge Centre | KAMPALA | province | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 04 | 1 | CDC | 3/7/2024 | $0 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002306 | Sustaining Local Efforts for Epidemic Control | 03 | 4 | CDC | 4/23/2024 | $0 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002306 | Sustaining Local Efforts for Epidemic Control | 03 | 4 | CDC | 4/23/2024 | $0 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 05 | 1 | CDC | 3/22/2024 | $0 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-McKinnell Knowledge Centre | KAMPALA | province | | | UGA | NU2GGH002508 | Achieving and Sustaining HIV and TB Epidemic Control in Wakiso & Masaka Regions of Uganda through Scale Up of Innovative Evidence-Based Interventions towards Achievement of UNAIDS 95:95:95 Targets | 03 | 1 | CDC | 2/26/2024 | $14,319,242 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | R01AI160434 | Clinical Predictors of weekly Rifapentine/isoniazid related adverse drug reactions during national roll-out of tuberculosis preventive therapy | 000 | 4 | NIH | 7/22/2024 | $140,663 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002306 | Sustaining Local Efforts for Epidemic Control | 04 | 4 | CDC | 5/20/2024 | $0 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002306 | Sustaining Local Efforts for Epidemic Control | 04 | 4 | CDC | 5/20/2024 | $0 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002306 | Sustaining Local Efforts for Epidemic Control | 05 | 4 | CDC | 6/13/2024 | $0 |
| 2024 | 2024 | THE INFECTIOUS DISEASES INSTITUTE LIMITED | IDI-MCKINNELL KNOWLEDGE CENTRE | KAMPALA | | | | UGA | NU2GGH002306 | Sustaining Local Efforts for Epidemic Control | 05 | 4 | CDC | 6/13/2024 | $0 |
|